Press Releases
DENTSPLY International Names Willie A. Deese As Director
Stock quotes in this article:XRAY
YORK, Pa., Feb. 11, 2011 (GLOBE NEWSWIRE) -- DENTSPLY International Inc. (Nasdaq:XRAY) announced today that Willie A. Deese has been appointed to serve as a member of the Board of Directors with his initial term expiring at the 2012 Annual Meeting of Shareholders. Mr. Deese is Executive Vice President of Merck & Co., Inc. and has been President of the Merck Manufacturing Division since May 2005. In this role, Mr. Deese oversees 92 manufacturing sites spanning 30 countries, has led manufacturing for the introduction of multiple new medicines and vaccines, and implemented lean manufacturing across the company's manufacturing network. Mr. Deese joined Merck, a $46 billion global biopharmaceutical company, in January 2004 as Senior Vice President of Global Procurement. Throughout his career, Mr. Deese has been actively involved in the operational and financial aspects of several market leading companies, with more than a decade of senior executive experience. Mr. Deese began his career in 1976 at Digital Equipment Corp. in Springfield, Mass. and joined SmithKline Beecham Pharmaceuticals in Philadelphia in 1992, ultimately becoming Vice President and Director, Purchasing. In 1996, Mr. Deese served as Vice President of Purchasing, at Kaiser Permanente in Oakland, Calif. In 1997, he returned to SmithKline Beecham as Senior Vice President and Director of Purchasing. Mr. Deese led the integration of the Glaxo and SmithKline procurement organizations through their merger, becoming Senior Vice President, Global Procurement and Logistics for GlaxoSmithKline in 2001. Mr. Deese earned his B.A. in Business Administration at North Carolina A&T State University in 1977, and his M.B.A. at Western New England College in 1983. Bret Wise, DENTSPLY's Chairman and Chief Executive Officer, states, "Our Company is pleased to have someone with Mr. Deese's broad executive experience and talent join our Board of Directors. Willie is highly regarded in the pharmaceutical industry and will contribute to DENTSPLY's successful achievement of strategic business initiatives."
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |



Connect with TheStreet